The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pharma Sterile Fill-Finish CDMO Market Research Report 2024
Synopsis
In pharmaceutical manufacturing, fill-finish operations are critical, since fill-finish is the last step before a product is packaged and ultimately delivered to the patient. By the time a drug reaches this stage, the drug product is highly valuable, as it has already been through labour- and cost-intensive production stages, including upstream processing, cell culture or fermentation and downstream purification. Failures in the integrity of the fill-finish stage can introduce microbial contamination and generate issues with formulation and dosing
The global Pharma Sterile Fill-Finish CDMO market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Pharma Sterile Fill-Finish CDMO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pharma Sterile Fill-Finish CDMO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Pharma Sterile Fill-Finish CDMO in Vaccines is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Pharma Sterile Fill-Finish CDMO include Baxter BioPharma Solutions, Boehringer Ingelheim, Vetter Pharma, Fresenius Kabi, Pfizer CentreOne, Aenova, WuXi Biologics, Jubilant HollisterStier, Bushu Pharmaceuticals, LSNE Contract Manufacturing, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pharma Sterile Fill-Finish CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma Sterile Fill-Finish CDMO.
The Pharma Sterile Fill-Finish CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharma Sterile Fill-Finish CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharma Sterile Fill-Finish CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter BioPharma Solutions
Boehringer Ingelheim
Vetter Pharma
Fresenius Kabi
Pfizer CentreOne
Aenova
WuXi Biologics
Jubilant HollisterStier
Bushu Pharmaceuticals
LSNE Contract Manufacturing
Ajinomoto Bio-Pharma Services
CMIC CMO
GRAM (Grand River Aseptic Manufacturing)
TAIYO Pharma Tech Co.,Ltd.
HALIX
Cognate BioServices
Afton Scientific
Novasep
Emergent BioSolutions
Seikagaku
Jiangshu YAOHAI Bio-pharmaceutical
Akron Biotech
Symbiosis Pharmaceutical Services
Techdow
Vigene Biosciences
Segment by Type
Vials
Prefilled Syringes
Cartridges
Others
Segment by Application
Vaccines
Biologics and Biosimilar
Generics
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharma Sterile Fill-Finish CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
In pharmaceutical manufacturing, fill-finish operations are critical, since fill-finish is the last step before a product is packaged and ultimately delivered to the patient. By the time a drug reaches this stage, the drug product is highly valuable, as it has already been through labour- and cost-intensive production stages, including upstream processing, cell culture or fermentation and downstream purification. Failures in the integrity of the fill-finish stage can introduce microbial contamination and generate issues with formulation and dosing
The global Pharma Sterile Fill-Finish CDMO market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Pharma Sterile Fill-Finish CDMO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pharma Sterile Fill-Finish CDMO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Pharma Sterile Fill-Finish CDMO in Vaccines is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Pharma Sterile Fill-Finish CDMO include Baxter BioPharma Solutions, Boehringer Ingelheim, Vetter Pharma, Fresenius Kabi, Pfizer CentreOne, Aenova, WuXi Biologics, Jubilant HollisterStier, Bushu Pharmaceuticals, LSNE Contract Manufacturing, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pharma Sterile Fill-Finish CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma Sterile Fill-Finish CDMO.
The Pharma Sterile Fill-Finish CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharma Sterile Fill-Finish CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharma Sterile Fill-Finish CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter BioPharma Solutions
Boehringer Ingelheim
Vetter Pharma
Fresenius Kabi
Pfizer CentreOne
Aenova
WuXi Biologics
Jubilant HollisterStier
Bushu Pharmaceuticals
LSNE Contract Manufacturing
Ajinomoto Bio-Pharma Services
CMIC CMO
GRAM (Grand River Aseptic Manufacturing)
TAIYO Pharma Tech Co.,Ltd.
HALIX
Cognate BioServices
Afton Scientific
Novasep
Emergent BioSolutions
Seikagaku
Jiangshu YAOHAI Bio-pharmaceutical
Akron Biotech
Symbiosis Pharmaceutical Services
Techdow
Vigene Biosciences
Segment by Type
Vials
Prefilled Syringes
Cartridges
Others
Segment by Application
Vaccines
Biologics and Biosimilar
Generics
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharma Sterile Fill-Finish CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharma Sterile Fill-Finish CDMO Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Vials
1.2.3 Prefilled Syringes
1.2.4 Cartridges
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pharma Sterile Fill-Finish CDMO Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Vaccines
1.3.3 Biologics and Biosimilar
1.3.4 Generics
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharma Sterile Fill-Finish CDMO Market Perspective (2019-2030)
2.2 Global Pharma Sterile Fill-Finish CDMO Growth Trends by Region
2.2.1 Global Pharma Sterile Fill-Finish CDMO Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharma Sterile Fill-Finish CDMO Historic Market Size by Region (2019-2024)
2.2.3 Pharma Sterile Fill-Finish CDMO Forecasted Market Size by Region (2025-2030)
2.3 Pharma Sterile Fill-Finish CDMO Market Dynamics
2.3.1 Pharma Sterile Fill-Finish CDMO Industry Trends
2.3.2 Pharma Sterile Fill-Finish CDMO Market Drivers
2.3.3 Pharma Sterile Fill-Finish CDMO Market Challenges
2.3.4 Pharma Sterile Fill-Finish CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharma Sterile Fill-Finish CDMO Players by Revenue
3.1.1 Global Top Pharma Sterile Fill-Finish CDMO Players by Revenue (2019-2024)
3.1.2 Global Pharma Sterile Fill-Finish CDMO Revenue Market Share by Players (2019-2024)
3.2 Global Pharma Sterile Fill-Finish CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharma Sterile Fill-Finish CDMO Revenue
3.4 Global Pharma Sterile Fill-Finish CDMO Market Concentration Ratio
3.4.1 Global Pharma Sterile Fill-Finish CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharma Sterile Fill-Finish CDMO Revenue in 2023
3.5 Global Key Players of Pharma Sterile Fill-Finish CDMO Head office and Area Served
3.6 Global Key Players of Pharma Sterile Fill-Finish CDMO, Product and Application
3.7 Global Key Players of Pharma Sterile Fill-Finish CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharma Sterile Fill-Finish CDMO Breakdown Data by Type
4.1 Global Pharma Sterile Fill-Finish CDMO Historic Market Size by Type (2019-2024)
4.2 Global Pharma Sterile Fill-Finish CDMO Forecasted Market Size by Type (2025-2030)
5 Pharma Sterile Fill-Finish CDMO Breakdown Data by Application
5.1 Global Pharma Sterile Fill-Finish CDMO Historic Market Size by Application (2019-2024)
5.2 Global Pharma Sterile Fill-Finish CDMO Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharma Sterile Fill-Finish CDMO Market Size (2019-2030)
6.2 North America Pharma Sterile Fill-Finish CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pharma Sterile Fill-Finish CDMO Market Size by Country (2019-2024)
6.4 North America Pharma Sterile Fill-Finish CDMO Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharma Sterile Fill-Finish CDMO Market Size (2019-2030)
7.2 Europe Pharma Sterile Fill-Finish CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pharma Sterile Fill-Finish CDMO Market Size by Country (2019-2024)
7.4 Europe Pharma Sterile Fill-Finish CDMO Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharma Sterile Fill-Finish CDMO Market Size (2019-2030)
8.2 Asia-Pacific Pharma Sterile Fill-Finish CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pharma Sterile Fill-Finish CDMO Market Size by Region (2019-2024)
8.4 Asia-Pacific Pharma Sterile Fill-Finish CDMO Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharma Sterile Fill-Finish CDMO Market Size (2019-2030)
9.2 Latin America Pharma Sterile Fill-Finish CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pharma Sterile Fill-Finish CDMO Market Size by Country (2019-2024)
9.4 Latin America Pharma Sterile Fill-Finish CDMO Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharma Sterile Fill-Finish CDMO Market Size (2019-2030)
10.2 Middle East & Africa Pharma Sterile Fill-Finish CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pharma Sterile Fill-Finish CDMO Market Size by Country (2019-2024)
10.4 Middle East & Africa Pharma Sterile Fill-Finish CDMO Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Baxter BioPharma Solutions
11.1.1 Baxter BioPharma Solutions Company Details
11.1.2 Baxter BioPharma Solutions Business Overview
11.1.3 Baxter BioPharma Solutions Pharma Sterile Fill-Finish CDMO Introduction
11.1.4 Baxter BioPharma Solutions Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
11.1.5 Baxter BioPharma Solutions Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Pharma Sterile Fill-Finish CDMO Introduction
11.2.4 Boehringer Ingelheim Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Vetter Pharma
11.3.1 Vetter Pharma Company Details
11.3.2 Vetter Pharma Business Overview
11.3.3 Vetter Pharma Pharma Sterile Fill-Finish CDMO Introduction
11.3.4 Vetter Pharma Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
11.3.5 Vetter Pharma Recent Development
11.4 Fresenius Kabi
11.4.1 Fresenius Kabi Company Details
11.4.2 Fresenius Kabi Business Overview
11.4.3 Fresenius Kabi Pharma Sterile Fill-Finish CDMO Introduction
11.4.4 Fresenius Kabi Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
11.4.5 Fresenius Kabi Recent Development
11.5 Pfizer CentreOne
11.5.1 Pfizer CentreOne Company Details
11.5.2 Pfizer CentreOne Business Overview
11.5.3 Pfizer CentreOne Pharma Sterile Fill-Finish CDMO Introduction
11.5.4 Pfizer CentreOne Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
11.5.5 Pfizer CentreOne Recent Development
11.6 Aenova
11.6.1 Aenova Company Details
11.6.2 Aenova Business Overview
11.6.3 Aenova Pharma Sterile Fill-Finish CDMO Introduction
11.6.4 Aenova Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
11.6.5 Aenova Recent Development
11.7 WuXi Biologics
11.7.1 WuXi Biologics Company Details
11.7.2 WuXi Biologics Business Overview
11.7.3 WuXi Biologics Pharma Sterile Fill-Finish CDMO Introduction
11.7.4 WuXi Biologics Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
11.7.5 WuXi Biologics Recent Development
11.8 Jubilant HollisterStier
11.8.1 Jubilant HollisterStier Company Details
11.8.2 Jubilant HollisterStier Business Overview
11.8.3 Jubilant HollisterStier Pharma Sterile Fill-Finish CDMO Introduction
11.8.4 Jubilant HollisterStier Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
11.8.5 Jubilant HollisterStier Recent Development
11.9 Bushu Pharmaceuticals
11.9.1 Bushu Pharmaceuticals Company Details
11.9.2 Bushu Pharmaceuticals Business Overview
11.9.3 Bushu Pharmaceuticals Pharma Sterile Fill-Finish CDMO Introduction
11.9.4 Bushu Pharmaceuticals Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
11.9.5 Bushu Pharmaceuticals Recent Development
11.10 LSNE Contract Manufacturing
11.10.1 LSNE Contract Manufacturing Company Details
11.10.2 LSNE Contract Manufacturing Business Overview
11.10.3 LSNE Contract Manufacturing Pharma Sterile Fill-Finish CDMO Introduction
11.10.4 LSNE Contract Manufacturing Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
11.10.5 LSNE Contract Manufacturing Recent Development
11.11 Ajinomoto Bio-Pharma Services
11.11.1 Ajinomoto Bio-Pharma Services Company Details
11.11.2 Ajinomoto Bio-Pharma Services Business Overview
11.11.3 Ajinomoto Bio-Pharma Services Pharma Sterile Fill-Finish CDMO Introduction
11.11.4 Ajinomoto Bio-Pharma Services Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
11.11.5 Ajinomoto Bio-Pharma Services Recent Development
11.12 CMIC CMO
11.12.1 CMIC CMO Company Details
11.12.2 CMIC CMO Business Overview
11.12.3 CMIC CMO Pharma Sterile Fill-Finish CDMO Introduction
11.12.4 CMIC CMO Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
11.12.5 CMIC CMO Recent Development
11.13 GRAM (Grand River Aseptic Manufacturing)
11.13.1 GRAM (Grand River Aseptic Manufacturing) Company Details
11.13.2 GRAM (Grand River Aseptic Manufacturing) Business Overview
11.13.3 GRAM (Grand River Aseptic Manufacturing) Pharma Sterile Fill-Finish CDMO Introduction
11.13.4 GRAM (Grand River Aseptic Manufacturing) Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
11.13.5 GRAM (Grand River Aseptic Manufacturing) Recent Development
11.14 TAIYO Pharma Tech Co.,Ltd.
11.14.1 TAIYO Pharma Tech Co.,Ltd. Company Details
11.14.2 TAIYO Pharma Tech Co.,Ltd. Business Overview
11.14.3 TAIYO Pharma Tech Co.,Ltd. Pharma Sterile Fill-Finish CDMO Introduction
11.14.4 TAIYO Pharma Tech Co.,Ltd. Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
11.14.5 TAIYO Pharma Tech Co.,Ltd. Recent Development
11.15 HALIX
11.15.1 HALIX Company Details
11.15.2 HALIX Business Overview
11.15.3 HALIX Pharma Sterile Fill-Finish CDMO Introduction
11.15.4 HALIX Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
11.15.5 HALIX Recent Development
11.16 Cognate BioServices
11.16.1 Cognate BioServices Company Details
11.16.2 Cognate BioServices Business Overview
11.16.3 Cognate BioServices Pharma Sterile Fill-Finish CDMO Introduction
11.16.4 Cognate BioServices Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
11.16.5 Cognate BioServices Recent Development
11.17 Afton Scientific
11.17.1 Afton Scientific Company Details
11.17.2 Afton Scientific Business Overview
11.17.3 Afton Scientific Pharma Sterile Fill-Finish CDMO Introduction
11.17.4 Afton Scientific Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
11.17.5 Afton Scientific Recent Development
11.18 Novasep
11.18.1 Novasep Company Details
11.18.2 Novasep Business Overview
11.18.3 Novasep Pharma Sterile Fill-Finish CDMO Introduction
11.18.4 Novasep Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
11.18.5 Novasep Recent Development
11.19 Emergent BioSolutions
11.19.1 Emergent BioSolutions Company Details
11.19.2 Emergent BioSolutions Business Overview
11.19.3 Emergent BioSolutions Pharma Sterile Fill-Finish CDMO Introduction
11.19.4 Emergent BioSolutions Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
11.19.5 Emergent BioSolutions Recent Development
11.20 Seikagaku
11.20.1 Seikagaku Company Details
11.20.2 Seikagaku Business Overview
11.20.3 Seikagaku Pharma Sterile Fill-Finish CDMO Introduction
11.20.4 Seikagaku Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
11.20.5 Seikagaku Recent Development
11.21 Jiangshu YAOHAI Bio-pharmaceutical
11.21.1 Jiangshu YAOHAI Bio-pharmaceutical Company Details
11.21.2 Jiangshu YAOHAI Bio-pharmaceutical Business Overview
11.21.3 Jiangshu YAOHAI Bio-pharmaceutical Pharma Sterile Fill-Finish CDMO Introduction
11.21.4 Jiangshu YAOHAI Bio-pharmaceutical Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
11.21.5 Jiangshu YAOHAI Bio-pharmaceutical Recent Development
11.22 Akron Biotech
11.22.1 Akron Biotech Company Details
11.22.2 Akron Biotech Business Overview
11.22.3 Akron Biotech Pharma Sterile Fill-Finish CDMO Introduction
11.22.4 Akron Biotech Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
11.22.5 Akron Biotech Recent Development
11.23 Symbiosis Pharmaceutical Services
11.23.1 Symbiosis Pharmaceutical Services Company Details
11.23.2 Symbiosis Pharmaceutical Services Business Overview
11.23.3 Symbiosis Pharmaceutical Services Pharma Sterile Fill-Finish CDMO Introduction
11.23.4 Symbiosis Pharmaceutical Services Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
11.23.5 Symbiosis Pharmaceutical Services Recent Development
11.24 Techdow
11.24.1 Techdow Company Details
11.24.2 Techdow Business Overview
11.24.3 Techdow Pharma Sterile Fill-Finish CDMO Introduction
11.24.4 Techdow Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
11.24.5 Techdow Recent Development
11.25 Vigene Biosciences
11.25.1 Vigene Biosciences Company Details
11.25.2 Vigene Biosciences Business Overview
11.25.3 Vigene Biosciences Pharma Sterile Fill-Finish CDMO Introduction
11.25.4 Vigene Biosciences Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
11.25.5 Vigene Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Pharma Sterile Fill-Finish CDMO Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Vials
Table 3. Key Players of Prefilled Syringes
Table 4. Key Players of Cartridges
Table 5. Key Players of Others
Table 6. Global Pharma Sterile Fill-Finish CDMO Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Pharma Sterile Fill-Finish CDMO Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Pharma Sterile Fill-Finish CDMO Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Pharma Sterile Fill-Finish CDMO Market Share by Region (2019-2024)
Table 10. Global Pharma Sterile Fill-Finish CDMO Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Pharma Sterile Fill-Finish CDMO Market Share by Region (2025-2030)
Table 12. Pharma Sterile Fill-Finish CDMO Market Trends
Table 13. Pharma Sterile Fill-Finish CDMO Market Drivers
Table 14. Pharma Sterile Fill-Finish CDMO Market Challenges
Table 15. Pharma Sterile Fill-Finish CDMO Market Restraints
Table 16. Global Pharma Sterile Fill-Finish CDMO Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Pharma Sterile Fill-Finish CDMO Market Share by Players (2019-2024)
Table 18. Global Top Pharma Sterile Fill-Finish CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma Sterile Fill-Finish CDMO as of 2023)
Table 19. Ranking of Global Top Pharma Sterile Fill-Finish CDMO Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Pharma Sterile Fill-Finish CDMO Revenue (CR5 and HHI) & (2019-2024)
Table 21. Global Key Players of Pharma Sterile Fill-Finish CDMO, Headquarters and Area Served
Table 22. Global Key Players of Pharma Sterile Fill-Finish CDMO, Product and Application
Table 23. Global Key Players of Pharma Sterile Fill-Finish CDMO, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pharma Sterile Fill-Finish CDMO Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Pharma Sterile Fill-Finish CDMO Revenue Market Share by Type (2019-2024)
Table 27. Global Pharma Sterile Fill-Finish CDMO Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Pharma Sterile Fill-Finish CDMO Revenue Market Share by Type (2025-2030)
Table 29. Global Pharma Sterile Fill-Finish CDMO Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Pharma Sterile Fill-Finish CDMO Revenue Market Share by Application (2019-2024)
Table 31. Global Pharma Sterile Fill-Finish CDMO Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Pharma Sterile Fill-Finish CDMO Revenue Market Share by Application (2025-2030)
Table 33. North America Pharma Sterile Fill-Finish CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Pharma Sterile Fill-Finish CDMO Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Pharma Sterile Fill-Finish CDMO Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Pharma Sterile Fill-Finish CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Pharma Sterile Fill-Finish CDMO Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Pharma Sterile Fill-Finish CDMO Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Pharma Sterile Fill-Finish CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Pharma Sterile Fill-Finish CDMO Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Pharma Sterile Fill-Finish CDMO Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Pharma Sterile Fill-Finish CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Pharma Sterile Fill-Finish CDMO Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pharma Sterile Fill-Finish CDMO Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Pharma Sterile Fill-Finish CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Pharma Sterile Fill-Finish CDMO Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Pharma Sterile Fill-Finish CDMO Market Size by Country (2025-2030) & (US$ Million)
Table 48. Baxter BioPharma Solutions Company Details
Table 49. Baxter BioPharma Solutions Business Overview
Table 50. Baxter BioPharma Solutions Pharma Sterile Fill-Finish CDMO Product
Table 51. Baxter BioPharma Solutions Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024) & (US$ Million)
Table 52. Baxter BioPharma Solutions Recent Development
Table 53. Boehringer Ingelheim Company Details
Table 54. Boehringer Ingelheim Business Overview
Table 55. Boehringer Ingelheim Pharma Sterile Fill-Finish CDMO Product
Table 56. Boehringer Ingelheim Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024) & (US$ Million)
Table 57. Boehringer Ingelheim Recent Development
Table 58. Vetter Pharma Company Details
Table 59. Vetter Pharma Business Overview
Table 60. Vetter Pharma Pharma Sterile Fill-Finish CDMO Product
Table 61. Vetter Pharma Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024) & (US$ Million)
Table 62. Vetter Pharma Recent Development
Table 63. Fresenius Kabi Company Details
Table 64. Fresenius Kabi Business Overview
Table 65. Fresenius Kabi Pharma Sterile Fill-Finish CDMO Product
Table 66. Fresenius Kabi Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024) & (US$ Million)
Table 67. Fresenius Kabi Recent Development
Table 68. Pfizer CentreOne Company Details
Table 69. Pfizer CentreOne Business Overview
Table 70. Pfizer CentreOne Pharma Sterile Fill-Finish CDMO Product
Table 71. Pfizer CentreOne Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024) & (US$ Million)
Table 72. Pfizer CentreOne Recent Development
Table 73. Aenova Company Details
Table 74. Aenova Business Overview
Table 75. Aenova Pharma Sterile Fill-Finish CDMO Product
Table 76. Aenova Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024) & (US$ Million)
Table 77. Aenova Recent Development
Table 78. WuXi Biologics Company Details
Table 79. WuXi Biologics Business Overview
Table 80. WuXi Biologics Pharma Sterile Fill-Finish CDMO Product
Table 81. WuXi Biologics Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024) & (US$ Million)
Table 82. WuXi Biologics Recent Development
Table 83. Jubilant HollisterStier Company Details
Table 84. Jubilant HollisterStier Business Overview
Table 85. Jubilant HollisterStier Pharma Sterile Fill-Finish CDMO Product
Table 86. Jubilant HollisterStier Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024) & (US$ Million)
Table 87. Jubilant HollisterStier Recent Development
Table 88. Bushu Pharmaceuticals Company Details
Table 89. Bushu Pharmaceuticals Business Overview
Table 90. Bushu Pharmaceuticals Pharma Sterile Fill-Finish CDMO Product
Table 91. Bushu Pharmaceuticals Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024) & (US$ Million)
Table 92. Bushu Pharmaceuticals Recent Development
Table 93. LSNE Contract Manufacturing Company Details
Table 94. LSNE Contract Manufacturing Business Overview
Table 95. LSNE Contract Manufacturing Pharma Sterile Fill-Finish CDMO Product
Table 96. LSNE Contract Manufacturing Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024) & (US$ Million)
Table 97. LSNE Contract Manufacturing Recent Development
Table 98. Ajinomoto Bio-Pharma Services Company Details
Table 99. Ajinomoto Bio-Pharma Services Business Overview
Table 100. Ajinomoto Bio-Pharma Services Pharma Sterile Fill-Finish CDMO Product
Table 101. Ajinomoto Bio-Pharma Services Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024) & (US$ Million)
Table 102. Ajinomoto Bio-Pharma Services Recent Development
Table 103. CMIC CMO Company Details
Table 104. CMIC CMO Business Overview
Table 105. CMIC CMO Pharma Sterile Fill-Finish CDMO Product
Table 106. CMIC CMO Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024) & (US$ Million)
Table 107. CMIC CMO Recent Development
Table 108. GRAM (Grand River Aseptic Manufacturing) Company Details
Table 109. GRAM (Grand River Aseptic Manufacturing) Business Overview
Table 110. GRAM (Grand River Aseptic Manufacturing) Pharma Sterile Fill-Finish CDMO Product
Table 111. GRAM (Grand River Aseptic Manufacturing) Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024) & (US$ Million)
Table 112. GRAM (Grand River Aseptic Manufacturing) Recent Development
Table 113. TAIYO Pharma Tech Co.,Ltd. Company Details
Table 114. TAIYO Pharma Tech Co.,Ltd. Business Overview
Table 115. TAIYO Pharma Tech Co.,Ltd. Pharma Sterile Fill-Finish CDMO Product
Table 116. TAIYO Pharma Tech Co.,Ltd. Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024) & (US$ Million)
Table 117. TAIYO Pharma Tech Co.,Ltd. Recent Development
Table 118. HALIX Company Details
Table 119. HALIX Business Overview
Table 120. HALIX Pharma Sterile Fill-Finish CDMO Product
Table 121. HALIX Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024) & (US$ Million)
Table 122. HALIX Recent Development
Table 123. Cognate BioServices Company Details
Table 124. Cognate BioServices Business Overview
Table 125. Cognate BioServices Pharma Sterile Fill-Finish CDMO Product
Table 126. Cognate BioServices Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024) & (US$ Million)
Table 127. Cognate BioServices Recent Development
Table 128. Afton Scientific Company Details
Table 129. Afton Scientific Business Overview
Table 130. Afton Scientific Pharma Sterile Fill-Finish CDMO Product
Table 131. Afton Scientific Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024) & (US$ Million)
Table 132. Afton Scientific Recent Development
Table 133. Novasep Company Details
Table 134. Novasep Business Overview
Table 135. Novasep Pharma Sterile Fill-Finish CDMO Product
Table 136. Novasep Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024) & (US$ Million)
Table 137. Novasep Recent Development
Table 138. Emergent BioSolutions Company Details
Table 139. Emergent BioSolutions Business Overview
Table 140. Emergent BioSolutions Pharma Sterile Fill-Finish CDMO Product
Table 141. Emergent BioSolutions Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024) & (US$ Million)
Table 142. Emergent BioSolutions Recent Development
Table 143. Seikagaku Company Details
Table 144. Seikagaku Business Overview
Table 145. Seikagaku Pharma Sterile Fill-Finish CDMO Product
Table 146. Seikagaku Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024) & (US$ Million)
Table 147. Seikagaku Recent Development
Table 148. Jiangshu YAOHAI Bio-pharmaceutical Company Details
Table 149. Jiangshu YAOHAI Bio-pharmaceutical Business Overview
Table 150. Jiangshu YAOHAI Bio-pharmaceutical Pharma Sterile Fill-Finish CDMO Product
Table 151. Jiangshu YAOHAI Bio-pharmaceutical Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024) & (US$ Million)
Table 152. Jiangshu YAOHAI Bio-pharmaceutical Recent Development
Table 153. Akron Biotech Company Details
Table 154. Akron Biotech Business Overview
Table 155. Akron Biotech Pharma Sterile Fill-Finish CDMO Product
Table 156. Akron Biotech Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024) & (US$ Million)
Table 157. Akron Biotech Recent Development
Table 158. Symbiosis Pharmaceutical Services Company Details
Table 159. Symbiosis Pharmaceutical Services Business Overview
Table 160. Symbiosis Pharmaceutical Services Pharma Sterile Fill-Finish CDMO Product
Table 161. Symbiosis Pharmaceutical Services Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024) & (US$ Million)
Table 162. Symbiosis Pharmaceutical Services Recent Development
Table 163. Techdow Company Details
Table 164. Techdow Business Overview
Table 165. Techdow Pharma Sterile Fill-Finish CDMO Product
Table 166. Techdow Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024) & (US$ Million)
Table 167. Techdow Recent Development
Table 168. Vigene Biosciences Company Details
Table 169. Vigene Biosciences Business Overview
Table 170. Vigene Biosciences Pharma Sterile Fill-Finish CDMO Product
Table 171. Vigene Biosciences Revenue in Pharma Sterile Fill-Finish CDMO Business (2019-2024) & (US$ Million)
Table 172. Vigene Biosciences Recent Development
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
Table 176. Authors List of This Report
List of Figures
Figure 1. Pharma Sterile Fill-Finish CDMO Picture
Figure 2. Global Pharma Sterile Fill-Finish CDMO Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pharma Sterile Fill-Finish CDMO Market Share by Type: 2023 VS 2030
Figure 4. Vials Features
Figure 5. Prefilled Syringes Features
Figure 6. Cartridges Features
Figure 7. Others Features
Figure 8. Global Pharma Sterile Fill-Finish CDMO Market Size by Application (2024-2030) & (US$ Million)
Figure 9. Global Pharma Sterile Fill-Finish CDMO Market Share by Application: 2023 VS 2030
Figure 10. Vaccines Case Studies
Figure 11. Biologics and Biosimilar Case Studies
Figure 12. Generics Case Studies
Figure 13. Other Case Studies
Figure 14. Pharma Sterile Fill-Finish CDMO Report Years Considered
Figure 15. Global Pharma Sterile Fill-Finish CDMO Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Pharma Sterile Fill-Finish CDMO Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Pharma Sterile Fill-Finish CDMO Market Share by Region: 2023 VS 2030
Figure 18. Global Pharma Sterile Fill-Finish CDMO Market Share by Players in 2023
Figure 19. Global Top Pharma Sterile Fill-Finish CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma Sterile Fill-Finish CDMO as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Pharma Sterile Fill-Finish CDMO Revenue in 2023
Figure 21. North America Pharma Sterile Fill-Finish CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Pharma Sterile Fill-Finish CDMO Market Share by Country (2019-2030)
Figure 23. United States Pharma Sterile Fill-Finish CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Pharma Sterile Fill-Finish CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Pharma Sterile Fill-Finish CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Pharma Sterile Fill-Finish CDMO Market Share by Country (2019-2030)
Figure 27. Germany Pharma Sterile Fill-Finish CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Pharma Sterile Fill-Finish CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Pharma Sterile Fill-Finish CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Pharma Sterile Fill-Finish CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Pharma Sterile Fill-Finish CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Pharma Sterile Fill-Finish CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Pharma Sterile Fill-Finish CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Pharma Sterile Fill-Finish CDMO Market Share by Region (2019-2030)
Figure 35. China Pharma Sterile Fill-Finish CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Pharma Sterile Fill-Finish CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Pharma Sterile Fill-Finish CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Pharma Sterile Fill-Finish CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Pharma Sterile Fill-Finish CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Pharma Sterile Fill-Finish CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Pharma Sterile Fill-Finish CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Pharma Sterile Fill-Finish CDMO Market Share by Country (2019-2030)
Figure 43. Mexico Pharma Sterile Fill-Finish CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Pharma Sterile Fill-Finish CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Pharma Sterile Fill-Finish CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Pharma Sterile Fill-Finish CDMO Market Share by Country (2019-2030)
Figure 47. Turkey Pharma Sterile Fill-Finish CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Pharma Sterile Fill-Finish CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. UAE Pharma Sterile Fill-Finish CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Baxter BioPharma Solutions Revenue Growth Rate in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
Figure 51. Boehringer Ingelheim Revenue Growth Rate in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
Figure 52. Vetter Pharma Revenue Growth Rate in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
Figure 53. Fresenius Kabi Revenue Growth Rate in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
Figure 54. Pfizer CentreOne Revenue Growth Rate in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
Figure 55. Aenova Revenue Growth Rate in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
Figure 56. WuXi Biologics Revenue Growth Rate in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
Figure 57. Jubilant HollisterStier Revenue Growth Rate in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
Figure 58. Bushu Pharmaceuticals Revenue Growth Rate in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
Figure 59. LSNE Contract Manufacturing Revenue Growth Rate in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
Figure 60. Ajinomoto Bio-Pharma Services Revenue Growth Rate in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
Figure 61. CMIC CMO Revenue Growth Rate in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
Figure 62. GRAM (Grand River Aseptic Manufacturing) Revenue Growth Rate in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
Figure 63. TAIYO Pharma Tech Co.,Ltd. Revenue Growth Rate in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
Figure 64. HALIX Revenue Growth Rate in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
Figure 65. Cognate BioServices Revenue Growth Rate in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
Figure 66. Afton Scientific Revenue Growth Rate in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
Figure 67. Novasep Revenue Growth Rate in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
Figure 68. Emergent BioSolutions Revenue Growth Rate in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
Figure 69. Seikagaku Revenue Growth Rate in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
Figure 70. Jiangshu YAOHAI Bio-pharmaceutical Revenue Growth Rate in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
Figure 71. Akron Biotech Revenue Growth Rate in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
Figure 72. Symbiosis Pharmaceutical Services Revenue Growth Rate in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
Figure 73. Techdow Revenue Growth Rate in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
Figure 74. Vigene Biosciences Revenue Growth Rate in Pharma Sterile Fill-Finish CDMO Business (2019-2024)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
